Brief: Viva Biotech Repurchases Of Us$29.9 Million Of $180 Mln Guaranteed Convertible Bonds
24/11/2022 15:04
Nov 24 (Reuters) - VIVA Biotech Holdings 1873.HK :
* REPURCHASED AGGREGATE PRINCIPAL AMOUNT OF US$29.9 MILLION
OF
US$180 MILLION 2.50 PER CENT GUARANTEED CONVERTIBLE BONDS DUE
2025 ON OPEN MARKET
* AFTER CANCELLATION OF REPURCHASED CONVERTIBLE BONDS,
AGGREGATE
PRINCIPAL AMOUNT OF US$6.6 MILLION OF CONVERTIBLE BONDS REMAIN
OUTSTANDING
Source text for Eikon: ID:nHKS1hxhq4
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical